Operaciones Applied Molecular Transport Inc. - AMTI CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.05 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Applied Molecular Transport Inc. ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Cierre previo* | 3.21 |
Abrir* | 3.03 |
Cambio de 1 año* | 2.36% |
Rango del día* | 2.93 - 3.13 |
Rango de 52 semanas | 0.21-4.17 |
Volumen medio (10 días) | 101.53K |
Volumen medio (3 meses) | 2.84M |
Capitalización de mercado | 10.47M |
Ratio P/E | -100.00K |
Acciones en circulación | 39.34M |
Ingresos | N/A |
EPS | -2.87 |
Dividendo (Rendimiento %) | N/A |
Beta | -100.00K |
Próxima fecha de resultados | Aug 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 2.96 | -0.07 | -2.31% | 3.03 | 3.13 | 2.91 |
Jun 28, 2022 | 3.21 | -0.40 | -11.08% | 3.61 | 3.65 | 3.21 |
Jun 27, 2022 | 3.59 | -0.12 | -3.23% | 3.71 | 3.73 | 3.44 |
Jun 24, 2022 | 3.70 | 0.12 | 3.35% | 3.58 | 3.85 | 3.46 |
Jun 23, 2022 | 3.47 | 0.06 | 1.76% | 3.41 | 3.58 | 3.37 |
Jun 22, 2022 | 3.43 | 0.10 | 3.00% | 3.33 | 3.68 | 3.29 |
Jun 21, 2022 | 3.34 | 0.38 | 12.84% | 2.96 | 3.37 | 2.95 |
Jun 17, 2022 | 2.85 | 0.05 | 1.79% | 2.80 | 3.17 | 2.79 |
Jun 16, 2022 | 2.72 | -0.04 | -1.45% | 2.76 | 2.83 | 2.65 |
Jun 15, 2022 | 2.84 | -0.16 | -5.33% | 3.00 | 3.12 | 2.80 |
Jun 14, 2022 | 2.98 | -0.43 | -12.61% | 3.41 | 3.48 | 2.98 |
Jun 13, 2022 | 3.52 | -0.02 | -0.56% | 3.54 | 3.62 | 3.24 |
Jun 10, 2022 | 3.76 | -0.13 | -3.34% | 3.89 | 3.92 | 3.57 |
Jun 9, 2022 | 4.03 | 0.04 | 1.00% | 3.99 | 4.14 | 3.72 |
Jun 8, 2022 | 3.98 | 0.25 | 6.70% | 3.73 | 4.11 | 3.65 |
Jun 7, 2022 | 3.85 | 0.60 | 18.46% | 3.25 | 3.88 | 3.25 |
Jun 6, 2022 | 3.28 | 0.04 | 1.23% | 3.24 | 3.43 | 3.24 |
Jun 3, 2022 | 3.36 | 0.31 | 10.16% | 3.05 | 3.44 | 3.05 |
Jun 2, 2022 | 3.12 | 0.14 | 4.70% | 2.98 | 3.12 | 2.86 |
Jun 1, 2022 | 2.94 | -0.23 | -7.26% | 3.17 | 3.35 | 2.77 |
Applied Molecular Transport Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Wednesday, June 14, 2023 | ||
Hora (UTC) (UTC) 17:00 | País US
| Evento Applied Molecular Transport Inc. Annual Shareholders Meeting Applied Molecular Transport Inc. Annual Shareholders MeetingForecast -Previous - |
Wednesday, August 2, 2023 | ||
Hora (UTC) (UTC) 10:59 | País US
| Evento Q2 2023 Applied Molecular Transport Inc. Earnings Release Q2 2023 Applied Molecular Transport Inc. Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Hora (UTC) (UTC) 10:59 | País US
| Evento Q3 2023 Applied Molecular Transport Inc. Earnings Release Q3 2023 Applied Molecular Transport Inc. Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 127.219 | 100.789 | 66.682 | 28.29 | 29.868 |
Gastos de venta/general/administración Gastos, total | 37.393 | 29.341 | 12.746 | 3.974 | 1.938 |
Investigación y desarrollo | 89.826 | 71.448 | 53.936 | 24.316 | 27.93 |
Ingresos de explotación | -127.219 | -100.789 | -66.682 | -28.29 | -29.868 |
Ingresos por intereses (gastos), netos No operativos | 0.898 | 0.626 | 0.229 | 0.247 | 0 |
Ingresos netos antes de impuestos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Ingresos netos después de impuestos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Beneficio neto antes de partidas extra. Elementos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Ingresos netos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Beneficio neto diluido | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Promedio ponderado de acciones diluidas | 38.837 | 37.5915 | 22.8783 | 32.4006 | 32.4006 |
BPA diluido sin partidas extraordinarias | -3.2527 | -2.66781 | -2.90948 | -0.86551 | -0.92183 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
BPA normalizado diluido | -3.2527 | -2.66781 | -2.90948 | -0.86551 | -0.92183 |
Otros, netos | -0.004 | -0.124 | -0.111 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 28.483 | 23.095 | 25.526 | 36.022 | 42.576 |
Gastos de venta/general/administración Gastos, total | 6.752 | 8.655 | 7.288 | 10.113 | 11.337 |
Investigación y desarrollo | 12.988 | 14.44 | 18.238 | 25.909 | 31.239 |
Ingresos de explotación | -28.483 | -23.095 | -25.526 | -36.022 | -42.576 |
Ingresos por intereses (gastos), netos No operativos | 0.579 | 0.505 | 0.321 | 0.075 | -0.003 |
Otros, netos | -0.013 | -0.009 | -0.001 | 0.002 | 0.004 |
Ingresos netos antes de impuestos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Ingresos netos después de impuestos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Beneficio neto antes de partidas extra. Elementos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Ingresos netos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Beneficio neto diluido | -27.917 | -22.599 | -25.206 | -35.945 | -42.575 |
Promedio ponderado de acciones diluidas | 39.1884 | 39.0403 | 38.9146 | 38.7487 | 38.6414 |
BPA diluido sin partidas extraordinarias | -0.71238 | -0.57886 | -0.64773 | -0.92764 | -1.1018 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.48928 | -0.57886 | -0.64773 | -0.92764 | -1.1018 |
Gastos (ingresos) extraordinarios | 8.743 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 64.019 | 167.1 | 131.501 | 33.453 | 20.722 |
Efectivo e inversiones a corto plazo | 61.145 | 159.821 | 129.869 | 32.403 | 20.288 |
Efectivo y Equivalentes | 61.145 | 159.821 | 5.843 | 12.727 | 20.288 |
Inversiones a corto plazo | 0 | 124.026 | 19.676 | 0 | |
Prepaid Expenses | 2.688 | 6.685 | 1.311 | 0.65 | 0.434 |
Total Assets | 107.446 | 214.038 | 140.183 | 38.533 | 23.244 |
Property/Plant/Equipment, Total - Net | 41.989 | 45.792 | 8.447 | 4.091 | 2.358 |
Property/Plant/Equipment, Total - Gross | 51.036 | 55.245 | 11.894 | 5.774 | 3.335 |
Accumulated Depreciation, Total | -9.047 | -9.453 | -3.447 | -1.683 | -0.977 |
Long Term Investments | 0.249 | 0 | |||
Other Long Term Assets, Total | 1.438 | 1.146 | 0.235 | 0.74 | 0.164 |
Total Current Liabilities | 15.087 | 14.258 | 7.662 | 4.036 | 3.136 |
Accounts Payable | 1.583 | 2.211 | 3.174 | 2.666 | 2.831 |
Accrued Expenses | 13.299 | 11.81 | 4.173 | 1.315 | 0.305 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.083 | 0.013 | 0 | |
Total Liabilities | 46.608 | 50.451 | 8.51 | 4.62 | 3.637 |
Total Long Term Debt | 0.293 | 0.408 | 0.404 | 0.058 | 0 |
Other Liabilities, Total | 31.228 | 35.785 | 0.444 | 0.526 | 0.501 |
Total Equity | 60.838 | 163.587 | 131.673 | 33.913 | 19.607 |
Preferred Stock - Non Redeemable, Net | 105.615 | 63.747 | |||
Common Stock | 0.004 | 0.004 | 0.004 | 0.001 | 0.001 |
Additional Paid-In Capital | 426.804 | 403.228 | 271 | 1.078 | 0.61 |
Retained Earnings (Accumulated Deficit) | -365.97 | -239.645 | -139.358 | -72.794 | -44.751 |
Unrealized Gain (Loss) | 0 | 0.027 | 0.013 | 0 | |
Total Liabilities & Shareholders’ Equity | 107.446 | 214.038 | 140.183 | 38.533 | 23.244 |
Total Common Shares Outstanding | 39.1818 | 38.62 | 35.1214 | 32.4006 | 32.4006 |
Other Current Assets, Total | 0.186 | 0.594 | 0.321 | 0.4 | |
Current Port. of LT Debt/Capital Leases | 0.205 | 0.237 | 0.232 | 0.042 | |
Capital Lease Obligations | 0.293 | 0.408 | 0.404 | 0.058 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 46.32 | 64.019 | 80.277 | 101.308 | 133.182 |
Efectivo e inversiones a corto plazo | 41.771 | 61.145 | 76.02 | 95.83 | 126.48 |
Efectivo y Equivalentes | 41.771 | 61.145 | 76.02 | 95.83 | 126.48 |
Inversiones a corto plazo | |||||
Prepaid Expenses | 1.929 | 2.688 | 3.21 | 4.347 | 5.379 |
Other Current Assets, Total | 2.62 | 0.186 | 1.047 | 1.131 | 1.323 |
Total Assets | 83.295 | 107.446 | 124.607 | 147.262 | 181.689 |
Property/Plant/Equipment, Total - Net | 35.564 | 41.989 | 42.865 | 44.606 | 47.159 |
Property/Plant/Equipment, Total - Gross | 36.122 | 51.036 | 57.131 | 58.073 | 58.913 |
Accumulated Depreciation, Total | -0.558 | -9.047 | -14.266 | -13.467 | -11.754 |
Other Long Term Assets, Total | 1.411 | 1.438 | 1.465 | 1.348 | 1.348 |
Total Current Liabilities | 16.819 | 15.087 | 14.124 | 16.209 | 18.499 |
Accounts Payable | 0.871 | 1.583 | 1.374 | 2.313 | 4.304 |
Accrued Expenses | 15.764 | 13.299 | 12.492 | 13.634 | 13.928 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.184 | 0.205 | 0.258 | 0.262 | 0.267 |
Total Liabilities | 47.151 | 46.608 | 46.212 | 49.51 | 53.844 |
Total Long Term Debt | 0.358 | 0.293 | 0.303 | 0.369 | 0.434 |
Capital Lease Obligations | 0.358 | 0.293 | 0.303 | 0.369 | 0.434 |
Other Liabilities, Total | 29.974 | 31.228 | 31.785 | 32.932 | 34.911 |
Total Equity | 36.144 | 60.838 | 78.395 | 97.752 | 127.845 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 430.027 | 426.804 | 421.762 | 415.913 | 410.061 |
Retained Earnings (Accumulated Deficit) | -393.887 | -365.97 | -343.371 | -318.165 | -282.22 |
Unrealized Gain (Loss) | 0 | ||||
Total Liabilities & Shareholders’ Equity | 83.295 | 107.446 | 124.607 | 147.262 | 181.689 |
Total Common Shares Outstanding | 39.201 | 39.1818 | 38.9431 | 38.8987 | 38.6542 |
Other Current Liabilities, Total |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -126.325 | -100.287 | -66.564 | -28.043 | -29.868 |
Efectivo de actividades de explotación | -93.9 | -82.609 | -58.894 | -26.967 | -27.45 |
Efectivo de actividades de explotación | 3.128 | 3.251 | 1.842 | 0.706 | 0.629 |
Partidas no monetarias | 31.54 | 21.064 | 2.942 | 0.468 | 0.34 |
Intereses pagados en efectivo | 0.027 | 0.032 | 0.014 | 0.002 | 0 |
Cambios en el capital circulante | -2.243 | -6.637 | 2.886 | -0.098 | 1.449 |
Efectivo de actividades de inversión | -4.152 | 122.206 | -109.286 | -22.134 | -0.545 |
Gastos de capital | -4.152 | -1.864 | -5.315 | -2.153 | -0.545 |
Otras partidas de flujo de caja de inversión, total | 0 | 124.07 | -103.971 | -19.981 | 0 |
Efectivo procedente de actividades de financiación | -0.733 | 115.298 | 161.296 | 41.648 | 30.926 |
Elementos de flujo de caja de financiación | -0.565 | -0.097 | -3.948 | -0.132 | 0 |
Emisión (retiro) de acciones, neto | 0.098 | 115.627 | 165.334 | 41.868 | 30.926 |
Emisión (amortización) de deuda, neta | -0.266 | -0.232 | -0.09 | -0.088 | 0 |
Variación neta de la tesorería | -98.785 | 154.895 | -6.884 | -7.453 | 2.931 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -27.917 | -126.325 | -103.726 | -78.52 | -42.575 |
Cash From Operating Activities | -19.298 | -93.9 | -79.084 | -59.52 | -31.131 |
Cash From Operating Activities | 0.701 | 3.128 | 2.468 | 1.791 | 0.911 |
Non-Cash Items | 8.082 | 31.54 | 24.718 | 16.953 | 9.042 |
Cash Interest Paid | 0.007 | 0.027 | 0.021 | 0.015 | 0.007 |
Changes in Working Capital | -0.164 | -2.243 | -2.544 | 0.256 | 1.491 |
Cash From Investing Activities | -0.007 | -4.152 | -4.146 | -3.923 | -1.517 |
Capital Expenditures | -0.061 | -4.152 | -4.146 | -3.923 | -1.517 |
Other Investing Cash Flow Items, Total | 0.054 | 0 | 0 | 0 | 0 |
Cash From Financing Activities | -0.069 | -0.733 | -0.68 | -0.548 | -0.693 |
Financing Cash Flow Items | 0 | -0.565 | -0.575 | -0.507 | -0.69 |
Issuance (Retirement) of Stock, Net | 0 | 0.098 | 0.098 | 0.091 | 0.06 |
Issuance (Retirement) of Debt, Net | -0.069 | -0.266 | -0.203 | -0.132 | -0.063 |
Net Change in Cash | -19.374 | -98.785 | -83.91 | -63.991 | -33.341 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
EPIQ Capital Group, LLC | Investment Advisor | 22.1706 | 8721447 | -47734 | 2023-03-31 | LOW |
Founders Fund | Venture Capital | 11.2823 | 4438222 | 0 | 2023-03-31 | LOW |
Mahmood (Tahir PH.D) | Individual Investor | 9.2155 | 3625189 | 4688 | 2023-04-03 | LOW |
Mrsny (Randall Ph.D) | Individual Investor | 9.1714 | 3607839 | 5454 | 2022-12-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.4347 | 1351143 | 0 | 2023-03-31 | LOW |
Lamond (David A.) | Individual Investor | 2.7391 | 1077519 | 162930 | 2023-04-03 | LOW |
Laurion Capital Management LP | Hedge Fund | 1.2243 | 481600 | 0 | 2023-03-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.1119 | 437408 | 427429 | 2023-03-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.0917 | 429457 | 1786 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.8643 | 340011 | -106776 | 2023-03-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 0.6845 | 269287 | -291413 | 2023-03-31 | HIGH |
VanDevender (Aaron Ph.D.) | Individual Investor | 0.5417 | 213109 | 450 | 2023-04-03 | LOW |
Millennium Management LLC | Hedge Fund | 0.4128 | 162377 | -116709 | 2023-03-31 | HIGH |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.386 | 151833 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3651 | 143609 | 0 | 2023-03-31 | LOW |
GSA Capital Partners LLP | Hedge Fund | 0.3186 | 125334 | -321277 | 2023-03-31 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.2542 | 100000 | 0 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.14 | 55055 | 0 | 2023-03-31 | LOW |
Rich (Douglas A) | Individual Investor | 0.1254 | 49316 | -482 | 2023-03-01 | LOW |
Bhatt (Elizabeth) | Individual Investor | 0.1239 | 48750 | 17250 | 2022-02-15 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Applied Molecular Transport Inc. Company profile
Sobre Applied Molecular Transport Inc.
Applied Molecular Transport Inc. es una empresa biofarmacéutica en fase clínica. La empresa aprovecha su plataforma tecnológica para diseñar y desarrollar una línea de productos biológicos orales candidatos para tratar enfermedades autoinmunes, inflamatorias y metabólicas, entre otras. La empresa está creando una cartera de productos orales candidatos basados en su plataforma tecnológica, entre ellos el AMT-101, una fusión oral de interleucina 10 (IL-10) selectiva para el tracto gastrointestinal (GI) que ha completado un ensayo clínico de fase 1b en pacientes con colitis ulcerosa (CU). El otro producto candidato de la empresa, el AMT-126, es una fusión oral selectiva GI de la interleucina 22 (IL-22). Su plataforma tecnológica le permite diseñar y desarrollar diversas modalidades terapéuticas biológicas orales, como péptidos, proteínas, anticuerpos completos, fragmentos de anticuerpos y terapias de ácido ribonucleico (ARN) con fármacos en fase de desarrollo.
El precio actual de la acción Applied Molecular Transport Inc. en tiempo real es 2.96 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: AECOM, 908 Devices Inc., Tingo Group, Shoe Carnival, Koninklijke Vopak N.V. y Ebang International Holdings Inc.. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Biotechnology & Medical Research (NEC) |
450 East Jamie Court
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com